Posts Tagged ‘AIDS’

Sabine Vollmer

Trial offers glimmer of hope for AIDS vaccine

Friday, December 18, 2009, 1:22 am By Sabine Vollmer

After taunting researchers for 30 years, HIV, the virus that causes AIDS, has relented a bit – at least that’s how many infectious disease experts are now interpreting results from two vaccine trials.

The first trial was a huge disappointment. The experimental vaccine, developed by U.S. drugmaker Merck, failed to prevent HIV infections so miserably, Merck halted the trial in September 2007. Two years later, results from the second trial were more promising. The trial was conducted in Thailand, involved more than 16,000 volunteers and used a combination of two vaccines. But three months after the results were released, questions persist whether the modest preventative effect of the Thai vaccine combo was real or due to chance.

Dr. Myron Cohen

Dr. Myron Cohen

Dr. Myron Cohen, a leading HIV/AIDS expert at the University of North Carolina, considers the results from the Thai vaccine trial “the first glimmer of hope” that there is a way to stop the spread of HIV/AIDS, particularly in poor countries. Read more…

Sabine Vollmer

RTP Weekahead 12/14

Monday, December 14, 2009, 12:04 am By Sabine Vollmer

Events taking place the week of Dec. 14 in the Research Triangle area that are open to the public: Read more…

Sabine Vollmer

NC voices: Dealing with HIV/AIDS 30 years into the epidemic

Monday, December 7, 2009, 7:05 pm By Sabine Vollmer

North Carolina’s Research Triangle Park area has been an epicenter for AIDS research for almost as long as HIV, the virus that causes the disease, has been on America’s mind.

For a closer look at what this means, Science in the Triangle talked to four North Carolinians familiar with battling HIV: Read more…

Sabine Vollmer

RTP Wrapup 12/4

Thursday, December 3, 2009, 11:07 pm By Sabine Vollmer

Winston-Salem drug development company Targacept adds a $1.24 billion deal to its partnship with British drugmaker AstraZeneca, Quintiles Transnational will add $400 million in debt to pay dividend and an AIDS researcher dares to speak of a cure. Read more…

Sabine Vollmer

AIDS: Closing in on a cure

Thursday, December 3, 2009, 3:04 pm By Sabine Vollmer

HIV

HIV

It took a generation, but researchers now dare to speak of a cure for HIV, the virus that triggered the AIDS epidemic in the late 1970s.

A laboratory experiment with a special mouse gives them hope.

Read more…

Sabine Vollmer

RTP Weekahead 11/30

Sunday, November 29, 2009, 4:17 pm By Sabine Vollmer

Events taking place the week of Dec. 30 in the Research Triangle area that are open to the public:

Read more…

Sabine Vollmer

RTP Wrapup 9/4

Thursday, September 3, 2009, 6:23 pm By Sabine Vollmer

A report offers hope that federal funds could become available for economic development in innovation hot spots such as the Research Triangle area, Bayer CropScience adds a research collaboration to recent efforts of creating better biotech seeds and Family Health International, a Durham organization that aims to improve public health worldwide, uses realty shows to stem the spread of HIV/AIDS.

Read more…